BackPrelude Therapeutics Overview

Prelude Therapeutics Research & Development

Research & Development expenses for PRLD.

Quarterly R&D Expenses

$13.60M
↓ 52.8% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$79.08M
↓ 33.77% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin